Changing Indications for Pediatric Heart Transplantation
نویسندگان
چکیده
منابع مشابه
Indications for Heart Transplantation in Pediatric Heart Disease
Background—Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indica...
متن کاملIndications for pediatric liver transplantation.
Two hundred fifty pediatric (less than 18 years of age) patients underwent orthotopic liver transplantation because of end-stage liver disease and were given combination therapy with cyclosporine and prednisone. The most common indications for transplantation in decreasing order of frequency were biliary atresia, inborn errors of metabolism, and postnecrotic cirrhosis. The 5-year actuarial surv...
متن کاملIndications for Heart Transplantation in Congenital Heart Disease
In this review we have looked at indications for cardiac transplantation in congenital heart disease. An outline of the general principles of the use of transplant as a management strategy both as a first line treatment and following other surgical interventions is discussed. We explore the importance of the timing of patient referral and the evaluations undertaken, and how the results of these...
متن کاملCurrent Indications of Bone Marrow Transplantation (BMT) in Pediatric Malignant Conditions a Review
Hematopoietic stem cell transplantation (HSCT) has been practiced for more than 30 years. Hematological malignanciesare the main indications for this treatment. However, its indications in adults are different from children.Advances in chemotherapy and target therapy have improved treatment outcome of some of the very high riskcancers, and changed indications of HSCT in children. Multi-center c...
متن کاملIndications for cardiac transplantation.
The prognosis of patients with end stage cardiac failure is poor. It can be improved by medical treatment, for example by adding vasodilators' or angiotensin converting enzyme inhibitors2 to diuretic treatment. None the less, the survival rate at 12 months in a group treated with enalapril was only 53%.2 At Papworth Hospital the cumulative survival rate for patients treated with "triple" immuno...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2015
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.114.001377